Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ligand Design. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110845547A details novel Pd-catalyzed asymmetric alkylation. Offers high ee values and mild conditions for indole derivatives manufacturing.
Patent CN102781948A details stable P-chiral aminodiphosphine ligands enabling high-ee asymmetric hydrogenation for cost-effective chiral pharmaceutical intermediates manufacturing.
Patent CN115385948A discloses silicon-centered spiro-bisoxazoline ligands enabling high-yield asymmetric carbene insertion. Ideal for reliable pharmaceutical intermediate supplier needs.
Patent CN102532225A details a novel methyl glucoside-derived ligand enabling high-yield asymmetric conjugate additions, offering cost-effective solutions for pharmaceutical intermediate manufacturing.
Patent CN114315906B discloses novel chiral phosphite ligands enabling high-yield asymmetric hydrosilylation and hydroformylation for reliable pharmaceutical intermediate supplier networks.
Patent CN111100124B discloses a novel linear phenanthroline ligand enhancing palladium catalyst efficiency. Discover cost-effective synthesis routes and supply chain advantages for industrial scale-up.
Patent CN101676293B details a novel indirect route for biimidazole phosphines, offering cost reduction in catalyst manufacturing and high-purity intermediates.
Patent CN116041393B reveals a novel N-N axis chiral ligand offering superior stereoselectivity and cost-effective synthesis for asymmetric catalysis applications.
Patent CN101717408B introduces a bis-phosphorus ylide ligand enabling high-yield alpha-arylation. This breakthrough offers significant cost reduction in API manufacturing and robust supply chain reliability.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity for asymmetric catalysis and cost-effective manufacturing.
Novel N-N axis chiral ligand synthesis via organocatalysis. High enantioselectivity for pharma intermediates. Cost-effective scalable route for complex molecule manufacturing.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity and cost-effective synthesis for asymmetric catalysis.
Patent CN111925356B details a novel chiral quinoline-imidazoline ligand synthesis enabling high-yield asymmetric difunctionalization for cost-effective API manufacturing.
Patent CN107459533B discloses stable phosphine ligands enabling low-loading palladium catalysis. Discover cost-effective solutions for pharmaceutical intermediate manufacturing.
Novel 5,5'-linked biphenyl ligands offering high stereoselectivity. Optimized synthesis for cost-effective pharmaceutical intermediate manufacturing and scalable production.
Novel 3-step synthesis of chiral imidazolone NHC precursors from bromoacetyl bromide. Enhances asymmetric catalysis efficiency and reduces manufacturing costs for pharmaceutical intermediates.
Solve asymmetric synthesis challenges with novel chiral nitrogen-diene ligands. 99% yield, 90% ee in rhodium-catalyzed reactions. Scale to 100 MT/annual with NINGBO INNO PHARMCHEM.